2006•Archives of Medical ResearchRequires access

Therapy in Type 2 Diabetes: Insulin Glargine vs. NPH Insulin Both in Combination with Glimepiride

Freddy Goldberg Eliaschewitz, C. Calvo, Humberto Valbuena, Maximino Ruiz, Pablo J. Aschner, Jaime E. Villena, Luis Alberto Ramírez, Jorge Tadeo Jiménez

Open publisher page 111 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 111 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Insulin glargine, Glimepiride, Medicine, NPH insulin, Hypoglycemia, Insulin, Internal medicine, Glycemic

Back to paper search Browse research topics Original source

Therapy in Type 2 Diabetes: Insulin Glargine vs. NPH Insulin Both in Combination with Glimepiride — Research Paper | ScholarLens